Biotech · Private company · Chapel Hill, NC, US

Transchromix, Llc.

Track this companyFree. Adds Transchromix, Llc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

Targeting novel translation mechanism to treat NFOO-induced hypoxia-related brain injuriesFiscal year 2026 · $400KNIH RePORTER 1R41DA064241-01 · fetched Nov 12, 2026
Novel brain-penetrant drugs for translation-targeting therapeutics of Alzheimer’s diseaseFiscal year 2024 · $497.2KNIH RePORTER 1R41AG085859-01 · fetched Nov 12, 2026